FDA Warns 2 Firms to Curb Their Claims About Green Tea

Two makers of green tea beverages have been warned by the U.S. Food and Drug Administration not to make unauthorized claims about nutrients in their products. The action reflects a continuing clampdown by the agency on misleading food labels, the Los Angeles Times reports.

The agency criticized the Dr Pepper Snapple Group for claiming that its Canada Dry Sparkling Green Tea Ginger Ale is “enhanced” with antioxidants. In a warning letter, the FDA said that ingredients in the drink supposedly containing antioxidants “are not nutrients with recognized antioxidant activity.”

In addition, agency said the company cannot make claims about the nutritional benefits of the carbonated beverage because it is classified as a snack food.

The FDA also reprimanded Unilever Inc. for health claims, made on a website for Lipton Green Tea 100% Naturally Decaffeinated, that linked consumption of green tea to reduced cholesterol for people at risk of heart disease. According to the agency, those kinds of claims would classify  the beverage as a drug, and make the product subject to requirements for proving safety and effectiveness. The agency also faulted the company for its claims about the tea’s antioxidant content.

In a statement, Unilever said it is “committed to full compliance with the law.” A Dr. Pepper Snapple Group spokesman said the company is “looking forward to working with the FDA and addressing the issues raised.”

Companies that receive warning letters are given 15 days to respond with a plan to fix violations.

Related Posts:

FDA Struggles to Keep Up With Misleading Drug Ads
Botox Maker to Pay $600 Million to Settle Illegal Marketing Charges

Print Print  

Like what we're doing? We'd appreciate your support.

Leave a comment